Toxicology Drug Testing Market Revenue to Cross USD 55.9 billion by 2031, Growing at a CAGR of 5.5% Says Transparency Market Research
28 août 2023 04h17 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global toxicology drug testing market is projected to flourish at a CAGR of 5.5% from...
Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.
04 oct. 2021 16h05 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Additional Vivarium Capacity at Facility in West Lafayette, IN
09 mars 2021 08h33 HE
|
Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., March 09, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of...
I.M. (Gina) Grossi, Ph.D., Joins Inotiv as Vice President of Toxicology to Drive Growth of Expanding Toxicology Business
11 août 2020 08h33 HE
|
Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“Inotiv”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of...
BASi Continues Revenue Growth in Third Quarter of Fiscal 2019
14 août 2019 08h33 HE
|
Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) today announced financial results for the three and nine...
Researchers Generate Better Data with BASi’s Redesigned Raturn™
21 mai 2019 08h53 HE
|
Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., May 21, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the launch of the Company’s redesigned Raturn™, a...
Certis Oncology Partners With Reveal Biosciences to Offer Advanced Pre-Clinical Oncology Services
13 août 2018 15h30 HE
|
Certis Oncology Solutions, Inc.
SAN DIEGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an...
Certis Oncology Announces CLIA Certification for High-Complexity Testing
16 juil. 2018 08h00 HE
|
Certis Oncology Solutions, Inc.
SAN DIEGO, July 16, 2018 (GLOBE NEWSWIRE) -- Certis Oncology Solutions, Inc., a new precision medicine company focused on individualized patient care, today announced that it has received its CLIA...
The Alliance for Regenerative Medicine Announces Third and Final Reimbursement and Market Access-Focused White Paper in Three-Part Series Published in In Vivo
12 juil. 2018 11h59 HE
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., July 12, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today announced the publication of its reimbursement and market-access focused white paper, “Moving...
Earth Science Tech, Inc. Signs Agreement with TransBiotech to start in Vitro & in Vivo in Phase II for Nutraceutical Patents
14 nov. 2017 08h00 HE
|
Earth Science Tech, Inc.
Doral, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of industrial hemp...